Walmart to launch online pet pharmacy and veterinary clinics
Category: #retail  By Pankaj Singh  Date: 2019-05-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

Walmart to launch online pet pharmacy and veterinary clinics

It is estimated that pet food spending will reach $31.68 billion in the year 2019.

Walmart, the world’s largest retailer, has reportedly announced to launch dozens of veterinary clinics more and its first online pet pharmacy to attract more pet owners in the U.S. who are spending billions of dollars each year on cats and dogs.

Reportedly, Walmart currently operates 21 veterinary clinics in its retail stores across 6 states. Over the next 12 months, the retailer is anticipated to increase that figure to 100. The expansion will start with the opening of 9 new veterinary clinics, later this month and into June, in the Dallas-Fort Worth area. Pets will be able to receive care for minor illness, vaccines and other routine exams at the new clinics.

Walmart will also launch WalmartPetRX.com, an online pet pharmacy, to compete with the e-commerce business of PetSmart, Chewy.com. Walmart will offer inexpensive prescriptions for cats, horses, livestock and dogs, from over 300 brands, cited reliable sources.

According to trusted sources, there has been a growth of almost 60 percent in the sum of cat- and dog-related health-care products sold on the website of Walmart over the past year.

Reportedly, in the U.S., more shoppers are pampering their pets, opting to spend a little more for better care and even organic food options. Last year, nearly $72.5 billion was spent on pets in the U.S. It is anticipated that spending will exceed $75.3 billion this year, compare with $60 billion splurged on pets just 4 years ago.

As per reliable sources, pet parents had spent $30.32 billion on food last year. Another $16.01 billion on supplies and over-the-counter medicines; $2.01 billion on purchasing the pets; $18.11 billion was spent on vet care; and $6.11 billion spent on other services.

It is estimated that food spending will reach to $31.68 billion in the year 2019. Vet care will reach $18.98 billion; $16.44 billion will be spent on supplies and medicines; $1.97 billion on animal purchases equating to; and other services costing $6.31 billion, cited trusted sources.

 

Source credit: https://www.cnbc.com/2019/05/06/walmart-to-open-dozens-of-vet-clinics-launch-online-pet-pharmacy.html

 

https://usaonlinejournal.com/2019/05/07/walmart-is-adding-vet-clinics-to-100-stores-and-launching-a-pet-pharmacy-as-millennials-spend-thousands-on-their-pets-and-treat-them-like-their-firstborn-child-wmt/



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...